We study progression and immune response in cancer, mechanisms of neurodegenerative diseases, RNA biology, probiotics and engineering of lactic acid bacteria, glycobiology and fungal proteins. Our goal is to use this knowledge for:
- understanding of disease mechanisms
- diagnostic and therapeutic purposes in medicine
- protection of the environment and preparation of quality and safe foods
News
Evaluating novel lipophilic fluorescent probes for reliable biofilm imaging
A new methodological paper from the Microbial Glycobiology group presents a comprehensive evaluation of fluorescent probes for biofilm labelling, with…
Successful defence of her doctoral dissertation
On Tuesday, March 4, 2025, our colleague Urša Čerček received the title PhD with a successful defence of her doctoral…
Minisymposium: Science for health
In December, as part of the annual meeting of the Biotechnology Program Group: Science for Health, we organized a minisymposi…
Fungal lectins show differential antiproliferative activity against cancer cells
We announce the publication of our study in the International Journal of Biological Macromolecules. The study, led by Dr. Jerica…
Exposure to fungal lectins impairs biofilm formation of Listeria
The researchers in the team led by Dr. Jerica Sabotič, in collaboration with colleagues from the Department of Condensed Matter…
New ARIS projects at the department
At this year’s project proposal call from national research agency ARIS projects form our colleagues Tina Vida Plavec, Milica Perišić…
New RSF project at the department
On this year’s first call for projects within the Development Pillar (RSF) of the Jožef Stefan Institute project from colleague…
Approaches to the treatment of Clostridioides difficile infection
Abida Zahirović, Borut Štrukelj and Aleš Berlec from the Department of Biotechnology at the Jožef Stefan Institute, in collaboration with…